Skip to main content
Skip to section navigation
Skip to footer
Our Platforms
Virax Immune
ViraxClear
Our Focus
T-Cell Testing
In Vitro Diagnostics
Resources
Investor Relations
Media Room
Blog
Events
About Us
Our Team
Careers
Partnership
Contact Us
Investors
Investors
Overview
News & Events
Overview
Press Releases
IR Calendar
Email Alerts
Company Info
Overview
Management Team
Presentations
Contacts
FAQ
Financial Info
Overview
Financial Results
Income Statement
Balance Sheet
Cash Flow
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
All SEC Filings
Filing Type:
View All
20-F
424B3
424B4
6-K
8-A12B
CERT
CORRESP
D
DRS
DRS/A
DRSLTR
EFFECT
F-1
F-1/A
FWP
NT 20-F
UPLOAD
Year:
View All
2023
2022
2021
Date
Form
Description
PDF
XBRL
Pages
03/22/23
F-1
Registration statement for securities of certain foreign private issuers
Documents
expand_more
EX-5
EX-21
EX-23
EX-FILING FEES
61
03/15/23
D
Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act.
5
03/10/23
6-K
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
Documents
expand_more
EX-10
EX-10
EX-10
EX-10
EX-10
EX-10
EX-99
EX-99
168
03/07/23
6-K
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
Documents
expand_more
EX-99
7
02/07/23
6-K
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
Documents
expand_more
EX-99.1
8
02/02/23
6-K
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
Documents
expand_more
EX-99.1
EX-99.2
27
02/02/23
6-K
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
Documents
expand_more
EX-99.1
9
01/04/23
6-K
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
Documents
expand_more
EX-99.1
7
12/06/22
6-K
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
Documents
expand_more
EX-99.1
7
12/02/22
424B3
Prospectus filed pursuant to Rule 424(b)(3)
33
rss_feed
Filing RSS
Page
1
Page
2
Page
3
Page
4
Page
5
Page
6
Next Page
arrow_forward
Email Alerts
Contacts
RSS News Feed